Discontinued — last reported Q4 '25

Business Segments · Expected restructuring costs

Corporate — Expected restructuring costs

Xylem Corporate — Expected restructuring costs decreased by 74.3% to $9.00M in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 74.3%, from $35.00M to $9.00M. This is a positive signal — lower values indicate better performance for this metric.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2016
Last reportedQ4 2025

How to read this metric

Higher expected costs indicate significant upcoming organizational changes, while lower costs suggest a more stable operational outlook.

Detailed definition

This represents the total estimated future costs that management anticipates incurring to execute planned restructuring...

Peer comparison

Typically disclosed in management discussion and analysis (MD&A) or restructuring footnotes.

Metric ID: xyl_segment_corporate_expected_restructuring_costs

Historical Data

5 periods
 Q4 '21Q4 '22Q4 '23Q4 '24Q4 '25
Value$0.00$0.00$34.00M$35.00M$9.00M
QoQ Change+2.9%-74.3%
YoY Change+2.9%-74.3%
Range$0.00$35.00M
Avg YoY Growth-35.7%
Median YoY Growth-35.7%

Frequently Asked Questions

What is Xylem's corporate — expected restructuring costs?
Xylem (XYL) reported corporate — expected restructuring costs of $9.00M in Q4 2025.
How has Xylem's corporate — expected restructuring costs changed year-over-year?
Xylem's corporate — expected restructuring costs decreased by 74.3% year-over-year, from $35.00M to $9.00M.
What does corporate — expected restructuring costs mean?
The total cost the company expects to spend on future restructuring projects.